Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
USE OF PIPAMPERONE AND A D2-RECEPTOR ANTAGONIST OR A SEROTONIN/DOPAMIN ANTAGONIST FOR THE TREATMENT OF PSYCHOTIC DISORDERS
No-Receipt date
2010-02087 - 22/06/2010
No-Filing date
20100401475 - 22/06/2010
No-Granting date
3072348 - 28/06/2010
No-EPO application date
04801138.1 - 02/12/2004
No-EPO granting date
1708790 - 21/04/2010
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2010 - 21/07/2010
Expiration date
03/12/2024
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US72596502/12/2003/US
CA245179802/12/2003/CA
EP0344727902/12/2003/EP
EP0444700105/01/2004/EP
US75242306/01/2004/US
EP0444706618/03/2004/EP
US80379318/03/2004/US
CA246124818/03/2004/CA
EP0402503521/10/2004/EP
JP200434908504/11/2004/JP
US98468309/11/2004/US
CA248752915/11/2004/CA
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/00
A61K 31/343
A61K 31/4545
A61K 31/519
A61P 25/18
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
323801
PHARMANEUROBOOST N.V.
ALKERSTRAAT 30A
3570 ALKEN
BELGIUM
Inventors
Code
Firstname
Surname
762664
BUNTINX, ERIK
Representatives
Code
Firstname
Surname
Address
Town
Zip
1349
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4007
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
7/2/2014 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 06/2014 Αρ. Πρωτ. Γ.Δ.559/2.7.2014
Payments history
9 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).